CGEM
Price
$7.61
Change
-$0.32 (-4.04%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
449.56M
70 days until earnings call
PROK
Price
$2.50
Change
+$0.01 (+0.40%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
337.48M
82 days until earnings call
Interact to see
Advertisement

CGEM vs PROK

Header iconCGEM vs PROK Comparison
Open Charts CGEM vs PROKBanner chart's image
Cullinan Therapeutics
Price$7.61
Change-$0.32 (-4.04%)
Volume$2.76K
Capitalization449.56M
ProKidney
Price$2.50
Change+$0.01 (+0.40%)
Volume$19.98K
Capitalization337.48M
CGEM vs PROK Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. PROK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a StrongBuy and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CGEM: $7.93 vs. PROK: $2.49)
Brand notoriety: CGEM and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 120% vs. PROK: 9%
Market capitalization -- CGEM: $449.56M vs. PROK: $337.48M
CGEM [@Biotechnology] is valued at $449.56M. PROK’s [@Biotechnology] market capitalization is $337.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 7 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • CGEM’s TA Score: 7 bullish, 1 bearish.
  • PROK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than PROK.

Price Growth

CGEM (@Biotechnology) experienced а +6.16% price change this week, while PROK (@Biotechnology) price change was +9.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 06, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($450M) has a higher market cap than PROK($337M). PROK YTD gains are higher at: 47.337 vs. CGEM (-34.893). PROK has higher annual earnings (EBITDA): -157.52M vs. CGEM (-234.39M). PROK has more cash in the bank: 295M vs. CGEM (265M). CGEM has less debt than PROK: CGEM (1.52M) vs PROK (4.42M). PROK has higher revenues than CGEM: PROK (527K) vs CGEM (0).
CGEMPROKCGEM / PROK
Capitalization450M337M134%
EBITDA-234.39M-157.52M149%
Gain YTD-34.89347.337-74%
P/E RatioN/AN/A-
Revenue0527K-
Total Cash265M295M90%
Total Debt1.52M4.42M34%
TECHNICAL ANALYSIS
Technical Analysis
CGEMPROK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 7 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCFBY5.620.62
+12.40%
Pacific Basin Shipping Ltd.
ABRMF0.15N/A
N/A
ARBOR METALS CORP.
PSPSY35.50N/A
N/A
PSP Swiss Property
GFLT10.43N/A
N/A
GenFlat Holdings, Inc.
ZIJMF3.19-0.01
-0.31%
Zijin Mining Group Company Ltd.

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
+3.80%
IDYA - CGEM
53%
Loosely correlated
+0.56%
BDTX - CGEM
49%
Loosely correlated
-1.03%
ATXS - CGEM
48%
Loosely correlated
-2.40%
TRDA - CGEM
47%
Loosely correlated
+1.25%
IMNM - CGEM
46%
Loosely correlated
-2.07%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+4.62%
RLYB - PROK
45%
Loosely correlated
-1.16%
NRIX - PROK
39%
Loosely correlated
+0.21%
APGE - PROK
38%
Loosely correlated
-0.21%
CGEM - PROK
37%
Loosely correlated
+3.80%
KYMR - PROK
37%
Loosely correlated
-3.67%
More